Musk的話 讓人聽了心裡一涼 他說我們 不該追求永生 否則社會就爛了 像骨頭僵硬一樣！ 啥？ 死亡竟是 進步的鑰匙？ 對 他說大多人死腦筋 死不了就會 永遠卡住新想法 年輕人帶來 革命思維 得靠老一輩 自然退場 才輪到他們上位 所以Elon警告 權力大叔們 不會鬆手 深層信念 是鐵板一塊 新世代難翻身 結果？ 社會像老樹枯朽 沒活力 停滯不前 這個說法 夠激進吧？ 但想想 歷史不就這樣？ 舊勢力不走 新火種燒不起 Elon不是反長壽 他也愛健康 延長壽命 誰不想要 多點好日子？ 但極端永生 像給社會上鎖 扼殺更新 AI和生物 科技熱潮中 這觀點超及時 長壽夢 會不會變噩夢？ 你是想活千歲 還是信Elon的 “死亡更新論”？ 這哲學炸彈 值不值得深思呢？. ...

容貌焦虑的风，终于吹进了硅谷。那帮整天围着 AI 转、大谈元宇宙的科技男们，现在也开始盯着镜子里的眼袋发愁了。 为了不被裁员，他们不仅拼命卷工作时长，还扎堆搞起了医美。这周打玻尿酸，下周做拉皮。一个月一次光子，一年一次热玛吉。 据《华尔街日报》调查，硅谷整形外科诊所的预约量半年暴涨 40%，三分之二客户是科技公司员工，平均年龄连 35 岁都不到。 这年头，技术不是铁饭碗，颜值才是生产力。有硅谷投资人甚至直接放话"不要雇 30 岁以上的人"。 因为在他们看来，年轻等于创造力。所以，多一条法令纹，就多一丝被"优化"的风险。 现在硅谷空气里，除了咖啡香，还飘着一股若有若无的麻药味。 富豪们的长生梦 别以为只有普通员工在意外貌，硅谷顶级富豪才是抗衰圈的 "终极卷王"。 只不过，他们担心的不是工作没了，而是人没了，钱没花完。 保持年轻只是入门级操作，返老还童、长生不老才是终极目标。 古代皇帝为了延年益寿，求仙问道，炼丹嗑药，现在的富豪们则更疯狂。 亚马逊创始人贝佐斯，一出手就想玩个大的。 他花 30 亿美金投资了一家细胞抗衰公司（Altos Labs）。致力于把全身 40-60 万亿个细胞全部换掉，重回婴儿状态，再活一 ...

Core Viewpoint - The article discusses the pursuit of anti-aging and longevity, focusing on Brian Johnson, a Silicon Valley entrepreneur who is actively exploring ways to extend human life through advanced technologies and personal health regimens [2][4][5]. Group 1: Brian Johnson's Approach to Anti-Aging - Brian Johnson aims to be the first person to attempt to avoid death, leveraging technology and personal health strategies [5][9]. - He has invested in a company called Blueprint, which monitors over 70 organs to create a personalized life algorithm [10]. - Johnson's daily regimen includes consuming 111 supplements and undergoing various cutting-edge treatments, including blood plasma therapy [23][25]. Group 2: The Silicon Valley Culture of Longevity - The pursuit of anti-aging is a common theme among wealthy Silicon Valley figures, with notable individuals investing heavily in biotechnology and health initiatives [6][8]. - Major tech entrepreneurs like Jeff Bezos and Mark Zuckerberg have also established companies focused on longevity, indicating a trend within the industry [8][9]. Group 3: Public Perception and Ethical Considerations - Johnson's methods, particularly blood plasma therapy, raise ethical questions, but he defends them by comparing the risks to those of unhealthy eating habits [25][26]. - His approach has attracted a following, suggesting a growing interest in anti-aging solutions among the public [28]. Group 4: Practical Advice for Longevity - Johnson emphasizes the importance of good nutrition, sleep, and exercise as fundamental components of a healthy lifestyle [30][31]. - He provides practical tips, such as maintaining a low resting heart rate before sleep, to help others improve their health without significant financial investment [29][30].

Core Viewpoint - Bryan Johnson, a Silicon Valley entrepreneur, is dedicated to anti-aging and longevity, investing significantly in various health technologies and practices to reverse his biological age and promote a healthier lifestyle [1][2][3]. Group 1: Personal Journey and Philosophy - Johnson's journey into anti-aging began after selling his company for nearly $1 billion, leading him to explore how to live a more meaningful life [4][5]. - He emphasizes the importance of scientific measurement in health, advocating for a data-driven approach to understanding and improving personal health metrics [12][18]. - The concept of "Don't Die" is framed as a universal call to action, transcending cultural and ideological differences, focusing on the shared human desire to live [26][27]. Group 2: Health Practices and Findings - Johnson follows a strict regimen that includes low-calorie intake, regular exercise, and extensive supplementation, claiming that foundational practices like sleep, diet, and exercise account for 80% of health outcomes [19][21][36]. - He has publicly shared over 60 biomarkers related to health and longevity, aiming to create a measurable standard for health that can be replicated by others [13][34]. - The focus on resting heart rate before bed is highlighted as a key indicator of overall health, with specific recommendations for improving it through lifestyle changes [20][21]. Group 3: Community and Cultural Impact - Johnson has created support groups to foster accountability and community among individuals striving to improve their health, emphasizing the importance of social support in achieving health goals [24][25]. - He aims to shift cultural perceptions around health, making good health practices socially desirable and recognized [23][34]. - The initiative to establish a "Rejuvenation Olympics" encourages experimentation with various therapies to discover effective methods for slowing aging [31][34].

Core Viewpoint - The article discusses the extreme measures taken by Bryan Johnson, a Silicon Valley entrepreneur, in his pursuit of anti-aging and longevity, including blood transfusions and a rigorous supplement regimen, while questioning the societal implications of such pursuits [2][4][22]. Group 1: Bryan Johnson's Anti-Aging Methods - Bryan Johnson consumes 111 supplements daily and has invested in various advanced therapies, including gene therapy and blood plasma therapy, to slow down his aging process [9][22]. - He has developed a personalized life algorithm by monitoring over 70 organs, aiming to optimize his health and longevity [9][20]. - Johnson's aging coefficient is reported to be 0.54, indicating he has effectively slowed his biological aging compared to the average [18][20]. Group 2: Societal and Ethical Implications - The article raises questions about the ethical boundaries of Johnson's methods, particularly his blood transfusion practices with his son, which have sparked public debate [22][24]. - Johnson compares the risks of his therapies to the dangers of fast food consumption, suggesting that societal norms around health and risk are misaligned [24][25]. - The pursuit of anti-aging is framed as a broader trend among wealthy Silicon Valley figures, highlighting a cultural obsession with overcoming mortality [6][8]. Group 3: General Health Recommendations - Despite his extreme measures, Johnson emphasizes basic health principles such as proper diet, sleep, and exercise, suggesting that these are foundational to longevity [15][30]. - He proposes a structured daily routine to optimize health, including specific meal timing to improve sleep quality and overall well-being [29][30].

Core Insights - The article discusses Brian Johnson, a wealthy American entrepreneur, who is pursuing extreme anti-aging methods and aims to achieve a form of immortality through various scientific and lifestyle interventions [1][4][5]. Group 1: Brian Johnson's Anti-Aging Philosophy - Johnson spends over $2 million annually on anti-aging efforts and follows a strict regimen that includes over a thousand interventions [4][12]. - He has developed a "Blueprint Protocol" that he claims has significantly slowed his aging process, with his biological age reportedly being 37 despite being 48 [12][19]. - Johnson's daily routine includes extensive health monitoring, a strict vegan diet, and various high-tech treatments, which he believes contribute to his health and longevity [10][11][12]. Group 2: Controversial Practices - Johnson has engaged in controversial practices such as multi-generational blood plasma exchange with his son and father, which he claims may have reversed some aging effects [32][34]. - He has also undergone gene therapy aimed at increasing muscle mass and strength, which raises ethical and safety concerns due to the experimental nature of such treatments [36][39]. - His approach to anti-aging has drawn comparisons to other tech billionaires who are investing in longevity research, highlighting a growing trend in Silicon Valley [25][27]. Group 3: Public Perception and Marketing - Johnson has cultivated a public persona that includes a "Don't Die" movement, which he promotes as a new ideology for longevity [48][49]. - He actively shares his health data and experiences, positioning himself as a "guinea pig" for anti-aging research, which has sparked both interest and skepticism [29][46]. - Critics argue that his methods may be more about marketing and personal branding than genuine scientific advancement, raising questions about the accessibility of such treatments for the general population [50][51].